Replies to post #31980 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Excellent points numbers. The clock's been ticking simply due to the fact that since going public in 2009 they still only have 2 fully commercialized generic drugs to show for all their efforts.

The past 4 years has been a huge disappointment on the ongoing ANDA and NDA pipeline development front.

But if Dr. Odidi can start finding a way to start unlocking the potential inherent value in his proprietary hyper-matrix nPODDS and PODRAS delivery tech platforms I still think a lot of positives can start to occur here over the course of the next 5 years.

PODRAS is gonna take 2 full years of extensive human trials to complete its R&D phase but if proven can become a blockbuster of true global proportions. So if they can provide proof positive data that they have in fact been completing additional studies during the back half of this year as they telegraphed, PODRAS progress/catalysts could definitely still be coming.

And they appear to be completing the required CAT 3 HAP studies on their oxy NDA candidate, with what appears to be heading for a timeline of receiving another potential PDUFA date and adcom scheduling by sometime next fall.

Also, they did complete a lot of maneuvering on their Regabatin patent at the USPTO this year, which seems to provide some hope that they're still actively seeking an R&D partner on that NDA candidate as well.

So as long as MNK starts increasing SeroquelXR sales in 2018 and the FDA approves their already partnered Pristiq and Lamictal ANDA's, attaining cash flow positive status by mid-2018 remains a real possibility and would finally put them on the path most still here thought they were on exactly 4 years ago now.

There's still some definite doubt which is reflected in the current share price and market apathy that's been affecting this stock since last summers Rexista adcom disaster...but I remain optimistic that Dr. Odidi will begin rising to the challenge next year forward and start creating some real progress that starts unlocking the potential inherent value in IPCI's pipeline.

[illmatix0711]

bonjour,

this is the last day, in 2017, to give us sth :)

i dont think we will hear anything but i have to admit i never expected this year to end around 0.7x $ and no perspective or
outlook in any way ...

also i thought we would get some other ANDA approved, but ok
why the hurry ?! haha

greetz and letz hope for at least a green closing of 2017 IPCI s shit year.

wish you all the best for 2018 and thx for all the support and knowledge you guys share in this thread.

see you next year :)